SCHOTT Continues Gains in U.S. Market, Invests for Future Organic Growth
An additional $23 million was invested in 2022 to support organic growth, bringing its five-year investment total to nearly $75 million.
- An additional $23 million was invested in 2022 to support organic growth, bringing its five-year investment total to nearly $75 million.
- Photo: SCHOTT
All of SCHOTT’s business units in the U.S. experienced growth, with pharmaceutical systems, home tech, and advanced optics leading the way. - SCHOTT has supplied more than 1,000 parts to the NIF and continues its role in the decades-long challenge of producing commercial-scale laser fusion energy.
- In 2023, SCHOTT is focused on advancing its core business units and making strong gains in the areas of med-tech, aerospace, and semiconductors.